Skip to content

Comparative evaluation of the outcomes of minimally invasive non-surgical therapy alone or in conjunction with either Enamel matrix derivative or hyaluronic acid for the treatment of participants with moderate intrabony defects: A Randomized controlled clinical trial.

Comparative evaluation of the outcomes of minimally invasive non-surgical therapy alone or in conjunction with either Enamel matrix derivative or hyaluronic acid for the treatment of moderate intrabony defects: A Randomized controlled clinical trial. - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103665
Enrollment
27
Registered
2026-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Group 3: MINST along with HA: Group 3 is Test group 2 in which after completion of MINST, 24% EDTA gel would be applied on the root surface of the involved tooth for 2 min. The site wou

Sponsors

Sudha Rustagi College of Dental Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Males and females aged more than or equal to 18 years. Patients with untreated severe or advanced periodontitis, that is, stage III or IV with slow or moderate rate of progression that is, grade A or B Presence of interdental periodontal defects with PD more than or equal to 5 mm associated with an intrabony component more than or equal to 2 mm at single rooted teeth or at molars with less than or equal to class I furcation involvement. One intrabony defect would be treated per patient. If multiple teeth presented pockets associated with an intrabony defect, only the site with the deepest PD would be selected for the study. In case of same PD in two or more intrabony defects per patient, the site with the deepest radiographic intrabony component would be selected. Patients with at least 10 teeth per arch.

Exclusion criteria

Exclusion criteria: -Patients with systemic diseases. -Pregnant or lactating females. -Tobacco smokers (more than or equal to 10 cigarettes per day). -Multi-rooted teeth with class II and class III furcation defects. -Third molars. -Teeth with grade III mobility. -Peri-apical pathology and acute abscess. -Patients without adequate level of oral hygiene -following step 1 of periodontal therapy (full-mouth plaque score [FMPS] of more than 20%). -Prolonged antibiotic treatment or anti-inflammatory treatment within 6 months prior to periodontal therapy -Non-surgical periodontal treatment in the past 6 months, or surgical periodontal treatment in the past 12 months -History of radiation therapy in the head and neck region -Presence of subgingival restoration which could interfere with clinical measurements

Design outcomes

Primary

MeasureTime frame
To assess and compare Probing Depth, Clinical Attachment Level, Radiographic defect fill and Radiographic defect angle before and after the treatment with MINST as a monotherapy, MINST in combination with EMD and MINST along with hyaluronic acid in treatment of patients with intrabony defects.Timepoint: post- intervention 3rd and 6th month

Secondary

MeasureTime frame
To assess and compare full mouth plaque score (FMPS), full mouth bleeding score (FMBS), gingival recession (measured from the CEJ to the gingival margin) in all the three groups i.e MINST as a monotherapy, MINST in combination with EMD and MINST along with hyaluronic acid in treatment of patients with intrabony defects.Timepoint: post- intervention 3rd and 6th month

Countries

India

Contacts

Public ContactDr Shivam Khanna

Sudha Rustagi College of Dental Sciences and Research

drmeenu2005@gmail.com09354281258

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026